Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has affected healthcare professionals and their response strategies. What You’ll Learn: Download out latest Instant Insights report […] The post IV Fluid Supply Chain Disruptions  appeared first on InCrowd ..read more

Can you introduce yourself? My name is Harrison Smith and I am physician practicing in the coastal southeastern United States. I am married to an emergency medicine physician and we currently have two beautiful and busy toddlers. What is your specialty? I am a board certified pulmonary and critical care physician. I have been fortunate […] The post How I Get Paid for Medical Surveys appeared first on InCrowd ..read more

Harnessing AI for Digital Transformation in Pharma Market Research Artificial Intelligence (AI) has been a hot topic in pharmaceutical market research. A lot of information is shared about AI and ML (machine learning), but how do you know which tools are worth the investment and which are just hype? This article shares how market research professionals can strategically embrace AI, enhance data science capabilities, and leverage cutting-edge AI tools proven to add value. This latest thinking is brought to you by an expert panel who took part in a dynamic discussion on the opportunities and ris ..read more

At InCrowd, we understand the urgency for timely, high-quality insights in the dynamic healthcare industry. Partnering with parent company Apollo Intelligence, we’ve identified the latest AI and ML innovations revolutionizing life science insights. Discover how these cutting-edge, agile approaches are delivering robust insights that drive meaningful change. Check out our latest innovation infographic. The post 5 Innovations Reshaping Today’s Insights Landscape appeared first on InCrowd ..read more

ASCO 2024, a pivotal conference for unveiling the latest advancements in cancer care, is just around the corner and oncologists are ready for it. A recent survey conducted by InCrowd provides exclusive insights into the minds of 530 oncologists, revealing their plans, preferences, and expectations for this highly anticipated conference. Attendance Outlook: An impressive 72% of oncologists, whether attending in-person or virtually, are gearing up for ASCO 2024, underscoring the event’s importance in the oncology community. Exciting Topics on the Horizon Topics ranging from groundbreaking resea ..read more

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and Hematology-Oncologists who attended the event, either in person or virtually. The survey aimed to achieve two objectives: Identify the medical condition that participants considered to have the most exciting data presented Understand the aspects of the presented data that they found particularly exciting. Download the report ..read more

HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb’s decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore the depth of this impact on patients Identify prevalent challenges faced by them Understand potential changes in patients’ political engagement post the abortion policy shift. Employing a 3-minute microsurvey, we engaged 145 US-based healthcare professionals (Primary Care Physicians, Pediatricians, Emergency Medicine practitioners, an ..read more

In December of 2023, InCrowd surveyed 105 US attending Physicians and Residents to explore the possibility of implementing AI into Healthcare settings. As technological advancements continue to advance, we are noticing an increase in the conversation surrounding Artificial Intelligence (AI) in Healthcare settings. But how do HCPs feel about AI integration? InCrowd surveyed US attending Physicians and Residents to gauge their attitude regarding the emerging trend of AI being implemented into their practice.  When asked about familiarity with AI functionality, 100% of the respondents said t ..read more

What Doctors thought of this year’s ESMO Event Fielded in less than 7 days, our 2023 Post-ESMO report sought to understand the event’s areas of greatest interest. 95 European oncologists and haematologist-oncologists shared with us the findings and developments they found most exciting. Our 2023 report includes responses from over 100 qualified US-based healthcare professionals (HCPs) familiar with the therapies considered in the research. Learn what respondents thought of the latest advancements including NSCLC, breast cancer, and Urothelial cancer treatments. Download the report today. The p ..read more

Prescriber Perceptions around CRISPR in 2023 Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise. In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR. This research reflects the comparisons of awareness between 2019 and 2023 of nucleic acid-based therapies with a specific focus on CRISPR. Our 2023 report includes responses from over 100 qualified US-based healthcare professionals ..read more